← Back to directory
QF
Qingsong Fund
Shenzhen, Guangdong, ChinaWebsite ↗
Qingsong Fund is a venture capital firm founded in 2012 by Liu Xiaosong, Dong Zhanbin, and Su Wei. It specializes in seed and early-stage investments, with a current focus on new energy, intelligent manufacturing, and the digital economy.
Last raised
Mar 2021
5y 6mo ago
Latest fund size
$152M
fourth RMB fund
AUM
—
Funds raised
Capital this firm has raised, newest first
tech fund
Unknown
$43M
fourth RMB fund
Mar 2021
$152M
Qingsong Fund III
Aug 2017
$129M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Shengfang Technology | — | — | Apr 2026 | |
| Volant Aerotech | Series B | — | Oct 2025 | |
| Suzhou MedEdge Medical | Series A | — | Jan 2025 | |
| Eccogene | Series B | — | Jun 2023 | |
| Shanghai B&C Pharmaceutical | Series C | — | Apr 2023 | |
| Tsingke Biotechnology | Series B | — | Dec 2022 | |
| .bit | Series A | — | Aug 2022 | |
| D-ID | Series A | — | Aug 2022 |
Sources
Where this data came from